NuVasive Investor Relations

SAN DIEGO, Aug. 23, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will participate in the following investor conferences:

• 2022 Wells Fargo Healthcare Conference, September 7, 2022, Boston. Chief Financial Officer Matt Harbaugh will be speaking at 3:10 p.m. ET.
• Morgan Stanley 20^th Annual Global Healthcare Conference, September 12, 2022, New York.  Chief Executive Officer Chris Barry and Chief Financial Officer Matt Harbaugh will be speaking at 11:40 a.m. ET.

A live webcast of the presentations will be available online from the Investor Relations page of the Company's website at www.nuvasive.com. After the live webcast, a replay of the presentations will remain available on the website for 30 days. 

About NuVasive

NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company's less-invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company's comprehensive procedural portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative neuromonitoring technology and service offerings. With more than $1 billion in net sales, NuVasive operates in more than 50 countries serving surgeons, hospitals, and patients. For more information, please visit www.nuvasive.com.

Forward-Looking Statements

NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons and hospitals, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products, the Company's ability to adequately manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvasive-to-participate-in-upcoming-investor-conferences-301610512.html

SOURCE NuVasive, Inc.

Investor, Juliet C. Cunningham, NuVasive, Inc., 858-210-2129, investorrelations@nuvasive.com; Media, Melanie Ordoñez, NuVasive, Inc., 858-722-3899, media@nuvasive.com